Fig. 4From: In vivo canine study of three different coatings applied to p64 flow-diverter stents: initial biocompatibility studyUnsubtracted angiographic series of the right subclavian artery (a) and left subclavian artery (b) of subject number 2 (treated with ASA only), implanted with HPC-2 and HPC-3 coated p64 devices, respectively, at day 28 (final angiographic control). a The right FDS almost occluded by an extensive in-stent thrombosis. b Complete occlusion of the left-sided deviceBack to article page